Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 26Lymphoma 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 11Neuroblastoma 10Lymphoma, Non-Hodgkin 10Central Nervous System Neoplasms 8Lymphoma, Follicular 6Hodgkin Disease 6Sarcoma 5Retinoblastoma 5Lymphoma, T-Cell, Peripheral 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Immunoblastic Lymphadenopathy 4Wilms Tumor 3Oligodendroglioma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Kidney Neoplasms 3Burkitt Lymphoma 3Astrocytoma 3Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Plasma Cell 2Neoplasms 2Multiple Myeloma 2Leukemia, T-Cell 2Leukemia, Biphenotypic, Acute 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

prednylidene 1pirarubicin 1etoposide phosphate 1Vincristine 1Prednisone 1Methotrexate 1Ifosfamide 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Subcutaneous panniculitis-like T-cell lymphoma × Vincristine × Clear all
NCT01746992 2017-11-14

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Ruijin Hospital

Phase 4 Unknown
200 enrolled
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡